Hvad er Y-tunnus-nummeret på Celgene Ab?

Celgene Ab er registreret hos PRH / YTJ under Y-tunnus 2095939-0.

Hvad er omsætningen for Celgene Ab?

Celgene Ab rapporterede en omsætning på EUR 1,7M i 2023.

Evristhenis Michalopoulos er administrerende direktør i Celgene Ab, i rollen siden 2023.

Celgene Abs registrerede adresse er Äyritie 18.

OYDissolved

Y-tunnus 2095939-0Äyritie 18, 01510 VantaaWholesale of pharmaceutical and medical goods· NACE 4646Est. 2007 · 19 years old— employeeswww.celgene.fi

Aktivt ansatte i selskabet

Name	Role	Member since
Current (2)
AK Anna Katarina Edsfors Äleskog Deputy Member	Deputy Member	2022
EM Evristhenis Michalopoulos Chief Executive Officer	Chief Executive Officer	2023
Former (4)
EM Evristhenis Michalopoulos Chief Executive Officer	Chief Executive Officer	2022 – 2023
SB Simone Böhrer Chief Executive Officer	Chief Executive Officer	2020 – 2022
JR Jani Roger Mantila Audit	Audit	2021 – 2023
KJ Kim Johan Järvi Audit	Audit	2012 – 2021

Ikke-udøvende tilsyn

Name	Role	Member since
Current (2)
JB Jörg Boris Schulze Board of Directors	Board of Directors	2023
AC Abdelhamid Chaaibi Board of Directors	Board of Directors	2022
Former (10)
NS Nakisa Serry Board of Directors	Board of Directors	2018 – 2020
SM Swati Mehta Board of Directors	Board of Directors	2020 – 2022
PE Patrick Eugene Flanigan III Board of Directors	Board of Directors	2018 – 2019
HM Hilde Mangseth Bech Chairperson	Chairperson	2022 – 2022
KR Katherine Reynolds Kelly Chairperson	Chairperson	2019 – 2021
SJ Stéphane Jacques C. Strebelle Board of Directors	Board of Directors	2022 – 2022
DW David Walter Pignolet Board of Directors	Board of Directors	2018 – 2021
IL Iddo Leshem Board of Directors	Board of Directors	2021 – 2022
MG Michaël Guislain Lugez Chairperson	Chairperson	2018 – 2019
TT Tuomo Tapani Pätsi Board of Directors	Board of Directors	2018 – 2020

Pr. seneste årsrapport

No shareholder data available.

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.